Delivery Order SPE2DB24D2018-SPE2DB24FWSB7
Award Date
4/5/24
Potential Completion Date
4/8/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. The order, valued at $3,922.62, has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $34,542.30, is for the supply of Dupixent 300 mg/2 ml pens to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds as the prime...
This is a $3,614.32 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pens. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of medical supplies and pharmaceuticals to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. The contract, valued at $13,845.88, has an ultimate completion date of March 18, 2024. This order is placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,709.46, is for the supply of Dupixent 300 mg/2 ml pens, a medication used to treat certain medical conditions. The award is not set-aside and has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Dupixent 200 mg/1.14 ml pens. The contract, valued at $13,475.37, has a period of performance through July 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the provision of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a ceiling value of $35,629.05 and a performance period through March 26, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) with a potential...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,452.32 order is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to provide a wide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The delivery order has a firm fixed price of $5,711.17 and a completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $9,914.10 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop...